Jianqing Lin

527 total citations
33 papers, 354 citations indexed

About

Jianqing Lin is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jianqing Lin has authored 33 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Pulmonary and Respiratory Medicine and 10 papers in Cancer Research. Recurrent topics in Jianqing Lin's work include Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (6 papers). Jianqing Lin is often cited by papers focused on Ferroptosis and cancer prognosis (8 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (6 papers). Jianqing Lin collaborates with scholars based in China, United States and Hong Kong. Jianqing Lin's co-authors include Qiao‐Nan Guo, Jianpeng Chen, Zhiyao Chen, Zhijun Huang, Feng Chen, Shuhua Wu, Jie Xu, Bin Li, Zhijun Huang and Yijie Guo and has published in prestigious journals such as ACS Nano, PLoS ONE and Cell Metabolism.

In The Last Decade

Jianqing Lin

32 papers receiving 354 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jianqing Lin China 10 202 115 72 55 47 33 354
Peilong Cao China 9 180 0.9× 114 1.0× 60 0.8× 40 0.7× 55 1.2× 17 356
Xiaowei Shen China 12 166 0.8× 94 0.8× 57 0.8× 60 1.1× 28 0.6× 35 353
Zhining Liu China 11 164 0.8× 89 0.8× 41 0.6× 38 0.7× 54 1.1× 28 386
Yuanyi Wei China 12 196 1.0× 68 0.6× 76 1.1× 29 0.5× 28 0.6× 29 349
Chun Jin China 11 177 0.9× 116 1.0× 55 0.8× 112 2.0× 49 1.0× 17 394
Shumei Ma China 14 232 1.1× 122 1.1× 47 0.7× 52 0.9× 24 0.5× 40 432
Lifang Wu China 14 189 0.9× 108 0.9× 42 0.6× 29 0.5× 56 1.2× 23 424
Xiaoming Lin China 11 312 1.5× 181 1.6× 42 0.6× 44 0.8× 38 0.8× 35 453
Yanqing Jiang China 10 245 1.2× 64 0.6× 105 1.5× 28 0.5× 64 1.4× 16 454
Alessandro Salatino Italy 9 164 0.8× 97 0.8× 29 0.4× 41 0.7× 58 1.2× 19 329

Countries citing papers authored by Jianqing Lin

Since Specialization
Citations

This map shows the geographic impact of Jianqing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianqing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianqing Lin more than expected).

Fields of papers citing papers by Jianqing Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianqing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianqing Lin. The network helps show where Jianqing Lin may publish in the future.

Co-authorship network of co-authors of Jianqing Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Jianqing Lin. A scholar is included among the top collaborators of Jianqing Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianqing Lin. Jianqing Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Yinbo, Yunquan Zheng, Lian Chen, et al.. (2024). Lotus leaf Nuciferine improves sleep and reduces the low neuronal activity and brain tissue abnormalities associated with insomnia. Food Bioscience. 62. 105345–105345. 1 indexed citations
2.
Guo, Qiao‐Nan, et al.. (2024). Development of a nomogram for prediction of central lymph node metastasis of papillary thyroid microcarcinoma. BMC Cancer. 24(1). 235–235. 6 indexed citations
3.
Wang, Qiyuan, Tong Tong, Zhun Liu, et al.. (2023). Cysteine-Based Redox-Responsive Nanoparticles for Fibroblast-Targeted Drug Delivery in the Treatment of Myocardial Infarction. ACS Nano. 17(6). 5421–5434. 42 indexed citations
4.
Guo, Qiao‐Nan, et al.. (2023). Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancer. Scientific Reports. 13(1). 18198–18198. 9 indexed citations
5.
Chen, Zhiyao, et al.. (2023). Atractylenolide III ameliorated reflux esophagitis via PI3K/AKT/NF-κB/iNOS pathway in rats. Heliyon. 9(11). e21224–e21224. 7 indexed citations
6.
Xu, Jie, et al.. (2023). Circ_ZNF778_006 promoted ESCC progression by upregulating HIF-1α expression via sponging miR-18b-5p. Scientific Reports. 13(1). 19363–19363. 6 indexed citations
7.
Rao, Yuan James, et al.. (2023). Management of Localized Prostate Cancer in Men With Human Immunodeficiency Virus: Analysis of a Large Retrospective Cohort. Clinical Genitourinary Cancer. 21(5). 614.e1–614.e8.
9.
Xue, Cong, et al.. (2022). lncRNA-LET Regulates Glycolysis and Glutamine Decomposition of Esophageal Squamous Cell Carcinoma Through miR-93-5p/miR-106b-5p/SOCS4. Frontiers in Oncology. 12. 897751–897751. 8 indexed citations
10.
Guo, Qiao‐Nan, et al.. (2022). A pyroptosis-associated gene risk model for predicting the prognosis of triple-negative breast cancer. Frontiers in Oncology. 12. 890242–890242. 6 indexed citations
11.
12.
Guo, Qiao‐Nan, et al.. (2022). An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer. Scientific Reports. 12(1). 22322–22322. 13 indexed citations
13.
Guo, Qiao‐Nan, et al.. (2021). Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer. Frontiers in Immunology. 12. 736030–736030. 37 indexed citations
14.
Guo, Qiao‐Nan, et al.. (2021). Hsa-mir-3163 and CCNB1 may be potential biomarkers and therapeutic targets for androgen receptor positive triple-negative breast cancer. PLoS ONE. 16(11). e0254283–e0254283. 16 indexed citations
15.
Liu, Huiyong, et al.. (2020). Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells. Medical Science Monitor. 26. e922217–e922217. 16 indexed citations
16.
Lin, Jianqing, et al.. (2019). Effect of T‑cadherin on the AKT/mTOR signaling pathway, gastric cancer cell cycle, migration and invasion, and its association with patient survival rate. Experimental and Therapeutic Medicine. 17(5). 3607–3613. 7 indexed citations
17.
Lin, Jianqing, et al.. (2019). An NF90/long noncoding RNA-LET/miR-548k feedback amplification loop controls esophageal squamous cell carcinoma progression. Journal of Cancer. 10(21). 5139–5152. 7 indexed citations
18.
Lin, Jianqing, et al.. (2018). Differential diagnosis of multielements in cancerous and non-cancerous esophageal tissues. Talanta. 196. 585–591. 16 indexed citations
19.
Chen, Zhiyao, et al.. (2017). Up-regulated miR-548k promotes esophageal squamous cell carcinoma progression via targeting long noncoding RNA-LET. Experimental Cell Research. 362(1). 90–101. 27 indexed citations
20.
Lin, Jianqing, et al.. (2014). Antitumor Efficacy of Docetaxel-loaded Nanocarrier against Esophageal Cancer Cell Bearing Mice Model. Drug Research. 65(8). 403–409. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026